Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers finds that the trendy obesity drug is not cost-effective at its current price.
Losing weight is often the easy part; keeping it off is usually a struggle. In the POWERS study, Columbia researchers are now delving into the reasons why some people succeed and some fail.
Columbia researchers have discovered that a nanomaterial injected into mice shrinks fat at targeted locations, highlighting an unexpected strategy to treat obesity.
A study of mice found that dietary sugar alters the gut microbiome, setting off a chain of events that leads to metabolic disease, pre-diabetes, and weight gain.
A study of weight loss methods suggests that gastric bypass surgery is the best strategy for patients with type 2 diabetes and severe obesity, regardless of the severity of a patient’s diabetes.
Columbia University has announced that Barbara B. Kahn, MD, is the winner of its 2021 Naomi Berrie Award for Outstanding Achievement in Diabetes Research.
Relatives of people with type 1 diabetes are 15 times more likely than the general population to develop the disease, and studies at Columbia are trying to find ways to delay or stop the process.
Columbia obstetrician/gynecologist Noelia Zork on what people need to know about gestational diabetes—who is most at risk, how it is treated, and what you can do to prevent it.